{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:19:46Z","timestamp":1760833186252,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.nmd.2005.01.005","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T12:32:50Z","timestamp":1110544370000},"page":"321-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["129th ENMC International Workshop: Clinical Trials for Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy, 27th October 2004, Schiphol airport, The Netherlands"],"prefix":"10.1016","volume":"15","author":[{"given":"Richard","family":"Hughes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.nmd.2005.01.005_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003280.pub2","article-title":"Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Hughes","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.nmd.2005.01.005_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003217","article-title":"Immunosuppressants for treating multifocal motor neuropathy","author":"Umapathi","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nmd.2005.01.005_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0960-8966(00)00191-7","article-title":"Report of a european workshop on multifocal motor neuropathy","volume":"11","year":"2001","journal-title":"Neuromuscul Disord"},{"issue":"2 Suppl. 5","key":"10.1016\/j.nmd.2005.01.005_bib4","first-page":"A490","article-title":"Design of a dose-ranging study to determine the safety and efficacy of intramuscular interferon beta-1a (Avonex\u00ae) when used in subjects with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)","volume":"62","author":"Ropper","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2005.01.005_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00019052-200206000-00009","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy","volume":"15","author":"Pollard","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nmd.2005.01.005_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0165-5728(01)00266-1","article-title":"Multifocal motor neuropathy","volume":"115","author":"Nobile-Orazio","year":"2001","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.nmd.2005.01.005_bib7","article-title":"Methotrexate for treating rheumatoid arthritis","author":"Suarez-Almazor","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.nmd.2005.01.005_bib8","article-title":"Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis","author":"Ortiz","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nmd.2005.01.005_bib9","first-page":"440","article-title":"Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases","volume":"72","author":"Chaudhry","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2005.01.005_bib10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1212\/01.WNL.0000134676.05850.C0","article-title":"Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy","volume":"63","author":"Gorson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2005.01.005_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-510X(01)00478-6","article-title":"Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis","volume":"185","author":"Mowzoon","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2005.01.005_bib12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1468-1331.2002.00478.x","article-title":"Mycophenolate in treatment-resistant inflammatory neuropathies","volume":"9","author":"Umapathi","year":"2002","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2005.01.005_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1081-1206(10)63607-1","article-title":"Mycophenolate mofetil: new applications for this immunosuppressant","volume":"90","author":"Moder","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.nmd.2005.01.005_bib14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1196\/annals.1254.064","article-title":"Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study","volume":"998","author":"Meriggioli","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.nmd.2005.01.005_bib15","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jnnp.72.5.596","article-title":"Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies","volume":"72","author":"Merkies","year":"2002","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.nmd.2005.01.005_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mus.10410","article-title":"Comparison between impairment and disability scales in immune-mediated polyneuropathies","volume":"28","author":"Merkies","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2005.01.005_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1477-7525-2-42","article-title":"The AMC linear disability score project in a population requiring residential care: psychometric properties","volume":"2","author":"Holman","year":"2004","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.nmd.2005.01.005_bib18","doi-asserted-by":"crossref","unstructured":"Dyck PJ, Hughes RAC, O'Brien PC. Quantitating overall neuropathic symptoms, impairments, and outcomes. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. Philadelphia: Saunders, 2005; in press.","DOI":"10.1016\/B978-0-7216-9491-7.50043-0"},{"key":"10.1016\/j.nmd.2005.01.005_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/mus.20022","article-title":"Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"29","author":"Van Den Bergh","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2005.01.005_bib20","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1212\/01.WNL.0000034172.47882.20","article-title":"Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy","volume":"59","author":"Thaisetthawatkul","year":"2002","journal-title":"Neurology"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896605000258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896605000258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:53:44Z","timestamp":1760774024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896605000258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0960896605000258"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2005.01.005","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"129th ENMC International Workshop: Clinical Trials for Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy, 27th October 2004, Schiphol airport, The Netherlands","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2005.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}